Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of 89Zr-DFO-nimotuzumab for Non-invasive Imaging of EGFR Positive Cancers by Positron Emission Tomography (PET)

NCT04235114 is registered in ClinicalTrials.gov with University of Saskatchewan as lead sponsor.

NCT NCT04235114
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04235114 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of 89Zr-DFO-nimotuzumab for Non-invasive Imaging of EGFR Positive Cancers by Positron Emission Tomography (PET)
Lead sponsor
University of Saskatchewan
Phase
Phase 1/2
Overall status
Recruiting
Start date
February 1, 2020
Completion date
December 31, 2026
Enrollment
14 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer, lung cancer